Theratechnologies (TH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 08-2021 | 05-2021 | 02-2021 | 11-2020 | 08-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 2,189 | 2,185 | 2,185 | 2,192 | 2,189 |
| Accounts receivable | -2,750 | 443 | 1,974 | -4,705 | 3,774 |
| Accounts payable and accrued liabilities | 2,843 | 1,968 | -3,984 | N/A | N/A |
| Other Working Capital | 1,421 | 2,096 | -3,332 | -4,402 | 3,521 |
| Other Operating Activity | -6,836 | -7,408 | -2,071 | 1,009 | -9,207 |
| Operating Cash Flow | $-3,133 | $-716 | $-5,228 | $-5,906 | $277 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -48 | -19 | -27 | -12 | -7 |
| Purchase Of Investment | -1,180 | -10,432 | -2 | -26 | -5 |
| Sale Of Investment | 0 | 203 | 437 | 1,547 | 701 |
| Purchase Sale Intangibles | 0 | -39 | N/A | 0 | 0 |
| Other Investing Activity | 47 | -352 | 32 | 46 | 57 |
| Investing Cash Flow | $-1,181 | $-10,639 | $440 | $1,555 | $746 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -159 | -160 | -158 | -151 | -141 |
| Common Stock Issued | 0 | 0 | 46,002 | N/A | N/A |
| Other Financing Activity | -1,257 | 534 | -4,676 | 0 | -5,153 |
| Financing Cash Flow | $-1,416 | $374 | $41,168 | $-151 | $-5,294 |
| Exchange Rate Effect | -59 | 100 | -1 | -3 | 73 |
| Beginning Cash Position | 38,235 | 49,116 | 12,737 | 17,242 | 21,440 |
| End Cash Position | 32,446 | 38,235 | 49,116 | 12,737 | 17,242 |
| Net Cash Flow | $-5,730 | $-10,981 | $36,380 | $-4,502 | $-4,271 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,133 | -716 | -5,228 | -5,906 | 277 |
| Capital Expenditure | -48 | -58 | -27 | -12 | -7 |
| Free Cash Flow | -3,181 | -774 | -5,255 | -5,918 | 270 |